p38 MAPK Inhibitor LY2228820 Dimesylate

The dimesylate salt form of LY2228820, a tri-substituted imidazole derivative and orally available, p38 mitogen-activated protein kinase (MAPK) inhibitor with potential anti-inflammatory and antineoplastic activities. Upon administration, LY2228820 inhibits the activity of p38, particularly the alpha and beta isoforms, thereby inhibiting MAPKAPK2 phosphorylation and preventing p38 MAPK-mediated signaling. This may inhibit the production of a variety of cytokines involved in inflammation, cellular proliferation and angiogenesis such as tumor necrosis factor alpha (TNFa), interleukin (IL)-1, -6 and -8, vascular endothelial growth factor, and macrophage inflammatory protein-1 alpha. Ultimately this induces apoptosis and reduces tumor cell proliferation. In addition, inhibition of the p38 MAPK pathway by LY2228820 increases the antineoplastic activity of certain chemotherapeutic agents. p38 MAPK, a serine/threonine protein kinase that is often upregulated in cancer cells, plays a crucial role in tumor cell proliferation, angiogenesis and metastasis. (NCI Thesaurus)

YOU MAY ALSO LIKE

P30 Cancer Center Support Grant

Funds awarded to certain U.S. institutions by the National Cancer Institute (NCI) for them to become cancer centers in the United States,…

P2Y Purinoceptor 8

P2Y purinoceptor 8 (359 aa, ~41 kDa) is encoded by the human P2RY8 gene. This protein plays a role in signal…

P2Y Purinoceptor 2

P2Y purinoceptor 2 (377 aa, ~42 kDa) is encoded by the human P2RY2 gene. This protein plays a role in ligand-dependent activation…

P2RY8/CRLF2 Fusion Gene

A fusion gene that results from an intrachromosomal deletion of the pseudoautosomal region 1of Xp22.3 and Yp11.3 which fuses the noncoding exon…

P2RY8 wt Allele

Human P2RY8 wild-type allele is located in the vicinity of Xp22.33 and Yp11.3 and is approximately 75 kb in length. This allele,…

P2RY8 Gene

This gene plays a role in signaling.